Clicky

Harrow Health, Inc.(HROW)

Description: Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.


Keywords: Pharmaceutical Pharmacy Infectious Diseases Pharmaceutical Sciences Ophthalmology Urology Drug Therapies Compounding Mcguff Companies

Home Page: www.harrowinc.com

HROW Technical Analysis

102 Woodmont Boulevard
Nashville, TN 37205
United States
Phone: 615 733 4730


Officers

Name Title
Mr. Mark L. Baum J.D. CEO & Chairman
Mr. Andrew R. Boll C.F.A., C.M.A., CFA, CMA CFO & Corp. Sec.
Dr. Robert J. Kammer D.D.S. Special Advisor
Mr. John P. Saharek MBA Chief Commercial Officer
Mr. David Moufarrège VP of Technology
Jamie Webb Director of Communications & Investor Relations
Dr. Dennis E Saadeh Pharm.D. Chief of Formulation Strategy
Dr. Larry M. Dillaha M.D. Chief Medical Officer
Mr. Andrew Livingston Chief Innovation Officer
Ms. Kim Barratt Chief Talent Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 287.6519
Price-to-Sales TTM: 4.0786
IPO Date: 2007-09-28
Fiscal Year End: December
Full Time Employees: 182
Back to stocks